Cargando…
Chimeric Agents Derived from the Functionalized Amino Acid, Lacosamide, and the α-Aminoamide, Safinamide: Evaluation of Their Inhibitory Actions on Voltage-Gated Sodium Channels, and Antiseizure and Antinociception Activities and Comparison with Lacosamide and Safinamide
[Image: see text] The functionalized amino acid, lacosamide ((R)-2), and the α-aminoamide, safinamide ((S)-3), are neurological agents that have been extensively investigated and have displayed potent anticonvulsant activities in seizure models. Both compounds have been reported to modulate voltage-...
Autores principales: | Park, Ki Duk, Yang, Xiao-Fang, Dustrude, Erik T., Wang, Yuying, Ripsch, Matthew S., White, Fletcher A., Khanna, Rajesh, Kohn, Harold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372064/ https://www.ncbi.nlm.nih.gov/pubmed/25418676 http://dx.doi.org/10.1021/cn5002182 |
Ejemplares similares
-
Efficacy of (S)-lacosamide in preclinical models of cephalic pain
por: Moutal, Aubin, et al.
Publicado: (2016) -
The effects of safinamide on dysphagia in Parkinson’s disease
por: Hirano, Makito, et al.
Publicado: (2023) -
Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain
por: Beyreuther, Bettina, et al.
Publicado: (2007) -
Safinamide: an add-on treatment for managing Parkinson’s disease
por: Müller, Thomas
Publicado: (2018) -
SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
por: Gómez-López, Ana, et al.
Publicado: (2021)